Corcept Therapeutics

CORT

Market cap $3.7B

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$95

169% upside

High target

positive

1 neutral

33%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Canaccord Genuity Edward Nash 67% 1-yr CORT win rate				2 Jan ‘26 14 days ago
HC Wainwright & Co Swayampakula Ramakanth 33% 1-yr CORT win rate				2 Jan ‘26 14 days ago
UBS Ashwani Verma				16 Dec ‘25 1 month ago
Wolfe Research Kalpit Patel				18 Nov ‘25 1 month ago